Shah RB - Search Results

1

The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.

Epstein JI, Amin MB, Fine SW, Algaba F, Aron M, Baydar DE, Beltran AL, Brimo F, Cheville JC, Colecchia M, Comperat E, da Cunha IW, Delprado W, DeMarzo AM, Giannico GA, Gordetsky JB, Guo CC, Hansel DE, Hirsch MS, Huang J, Humphrey PA, Jimenez RE, Khani F, Kong Q, Kryvenko ON, Kunju LP, Lal P, Latour M, Lotan T, Maclean F, Magi-Galluzzi C, Mehra R, Menon S, Miyamoto H, Montironi R, Netto GJ, Nguyen JK, Osunkoya AO, Parwani A, Robinson BD, Rubin MA, Shah RB, So JS, Takahashi H, Tavora F, Tretiakova MS, True L, Wobker SE, Yang XJ, Zhou M, Zynger DL, Trpkov K. Epstein JI, et al. Among authors: shah rb. Arch Pathol Lab Med. 2021 Apr 1;145(4):461-493. doi: 10.5858/arpa.2020-0015-RA. Arch Pathol Lab Med. 2021. PMID: 32589068 Free article. Review.

2

Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors.

Shah R, Bassily N, Wei J, Mucci NR, Montie JE, Sanda MG, Rubin MA. Shah R, et al. Urology. 2000 Nov 1;56(5):721-5. doi: 10.1016/s0090-4295(00)00775-5. Urology. 2000. PMID: 11068287

3

Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?

Shah R, Mucci NR, Amin A, Macoska JA, Rubin MA. Shah R, et al. Am J Pathol. 2001 May;158(5):1767-73. doi: 10.1016/S0002-9440(10)64132-6. Am J Pathol. 2001. PMID: 11337374 Free PMC article.

4

Delineation of prognostic biomarkers in prostate cancer.

Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM. Dhanasekaran SM, et al. Nature. 2001 Aug 23;412(6849):822-6. doi: 10.1038/35090585. Nature. 2001. PMID: 11518967 Free article.

5

Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.

Zhou M, Hayasaka S, Taylor JM, Shah R, Proverbs-Singh T, Manley S, Rubin MA. Zhou M, et al. J Urol. 2001 Dec;166(6):2193-7. J Urol. 2001. PMID: 11696734

6

Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.

Shah RB, Zhou M, LeBlanc M, Snyder M, Rubin MA. Shah RB, et al. Am J Surg Pathol. 2002 Sep;26(9):1161-8. doi: 10.1097/00000478-200209000-00006. Am J Surg Pathol. 2002. PMID: 12218572

7

Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.

Zhou M, Shah R, Shen R, Rubin MA. Zhou M, et al. Am J Surg Pathol. 2003 Mar;27(3):365-71. doi: 10.1097/00000478-200303000-00010. Am J Surg Pathol. 2003. PMID: 12604893

8

Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations.

Kunju LP, Rubin MA, Chinnaiyan AM, Shah RB. Kunju LP, et al. Among authors: shah rb. Am J Clin Pathol. 2003 Nov;120(5):737-45. doi: 10.1309/3T3Y-0K0T-UMYH-3WY2. Am J Clin Pathol. 2003. PMID: 14608901

9

Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer.

Kumar-Sinha C, Shah RB, Laxman B, Tomlins SA, Harwood J, Schmitz W, Conzelmann E, Sanda MG, Wei JT, Rubin MA, Chinnaiyan AM. Kumar-Sinha C, et al. Among authors: shah rb. Am J Pathol. 2004 Mar;164(3):787-93. doi: 10.1016/s0002-9440(10)63167-7. Am J Pathol. 2004. PMID: 14982833 Free PMC article.

10

Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations.

Shah RB, Kunju LP, Shen R, LeBlanc M, Zhou M, Rubin MA. Shah RB, et al. Am J Clin Pathol. 2004 Oct;122(4):517-23. doi: 10.1309/WRM5-1C70-P1NB-FE4K. Am J Clin Pathol. 2004. PMID: 15487448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page